2016
P002 The consistent inconsistency in HLA antibody testing practices: a collaboration with the Banff workgroup
Dadhania D, Jackson A, Campbell P, Bow L, Almeshari K, Schinstock C, Cornell L, Bagnasco S, Kraus E, Cozzi E, Askar M. P002 The consistent inconsistency in HLA antibody testing practices: a collaboration with the Banff workgroup. Human Immunology 2016, 77: 41. DOI: 10.1016/j.humimm.2016.07.067.Peer-Reviewed Original ResearchDonor-specific HLA antibodiesSingle antigen beadsHLA AbsAntigen beadsNon-sensitized patientsSpecific HLA antibodiesLarge transplant centerDifferent practice patternsDiagnosis of antibodyBanff criteriaHLA antibodiesSensitization statusSurveillance biopsiesPatients 54Transplant centersCombination of assaysPatient outcomesStrong antibodyPractice patternsPatient variesTesting practicesClinical relevanceHistocompatibility laboratoriesProzone effectAntibodies
2015
Novel antigen expression of HLA-DR53 in patients with DR7 and DQ9 haplotype
Rivera J, Rewinski M, Bow L, DeVivo J, Michalski T, Alberghini T, Doyle P. Novel antigen expression of HLA-DR53 in patients with DR7 and DQ9 haplotype. Human Immunology 2015, 76: 122. DOI: 10.1016/j.humimm.2015.07.171.Peer-Reviewed Original ResearchPositive B cell crossmatchB-cell crossmatchDR/DQAllocation of organsPossibility of antibodySerology typingHLA-DR53HLA phenotypesReflex testingCaucasian patientsLeukemia patientsReal-time PCRAntigen expressionOrgan donorsPatientsDR53 antigenDR53AntibodiesAdditional typingGenotype associationsAntigenTypingCommon null alleleRecipientsUnexpected expression
2012
39-P INCREASING MFI CUTOFFS FOR UNACCEPTABLE ANTIGENS INCREASES ACCESS TO ACTUAL DECEASED DONOR CROSSMATCHES FOR THE SENSITIZED RECIPIENT
Miller M, Alberghini T, Rewinski M, Bow L. 39-P INCREASING MFI CUTOFFS FOR UNACCEPTABLE ANTIGENS INCREASES ACCESS TO ACTUAL DECEASED DONOR CROSSMATCHES FOR THE SENSITIZED RECIPIENT. Human Immunology 2012, 73: 74. DOI: 10.1016/j.humimm.2012.07.165.Peer-Reviewed Original ResearchUnacceptable antigensB cellsB-cell crossmatchPositive flow crossmatchLow-level antibodyHLA class IResultsFifty-sixSensitized recipientsKidney transplantationPositive crossmatchFlow crossmatchVirtual crossmatchDonor workupDP antibodiesNegative control seraLuminex assaysCrossmatchHigh MFI valuesControl seraFlow cytometryMultiple antibodiesClass IRecipientsAntibodiesMatch runs
2010
A RETROSPECTIVE ANALYSIS OF THE CLINICAL SIGNIFICANCE OF SOLID PHASE ASSAY (LUMINEX) DETECTION OF PRE-TRANSPLANT HLA ANTIBODY AS MEASURED BY GRAFT OUTCOME IN RENAL TRANSPLANT RECIPIENTS
Bow L, Miller M, Alberghini T, Hull D, O'Sullivan D, Rewinski M, Lipkowitz G. A RETROSPECTIVE ANALYSIS OF THE CLINICAL SIGNIFICANCE OF SOLID PHASE ASSAY (LUMINEX) DETECTION OF PRE-TRANSPLANT HLA ANTIBODY AS MEASURED BY GRAFT OUTCOME IN RENAL TRANSPLANT RECIPIENTS. Transplantation 2010, 90: 526. DOI: 10.1097/00007890-201007272-00979.Peer-Reviewed Original Research